Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1968 1
1970 1
1971 2
1972 4
1973 6
1974 7
1975 6
1976 8
1977 3
1978 3
1979 4
1980 7
1981 5
1982 3
1983 3
1984 2
1985 6
1986 3
1987 2
1988 3
1989 4
1990 4
1991 2
1992 2
1993 4
1994 2
1995 4
1996 6
1997 4
1998 5
1999 3
2000 1
2001 3
2002 3
2003 2
2005 3
2006 5
2007 3
2008 5
2009 6
2010 6
2011 8
2012 6
2013 6
2014 7
2015 7
2016 5
2017 4
2018 2
2019 1
2020 6
2021 6
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Understanding shoulder pseudoparalysis. Part II: Treatment.
Coward JC, Bauer S, Babic SM, Coron C, Okamoto T, Blakeney WG. Coward JC, et al. EFORT Open Rev. 2022 Mar 17;7(3):227-239. doi: 10.1530/EOR-21-0070. EFORT Open Rev. 2022. PMID: 35298409 Free PMC article. Review.
Mucinous ovarian cancer: A therapeutic review.
Xu W, Rush J, Rickett K, Coward JI. Xu W, et al. Among authors: coward ji. Crit Rev Oncol Hematol. 2016 Jun;102:26-36. doi: 10.1016/j.critrevonc.2016.03.015. Epub 2016 Mar 19. Crit Rev Oncol Hematol. 2016. PMID: 27083591 Review.
Interleukin-6: an angiogenic target in solid tumours.
Middleton K, Jones J, Lwin Z, Coward JI. Middleton K, et al. Among authors: coward ji. Crit Rev Oncol Hematol. 2014 Jan;89(1):129-39. doi: 10.1016/j.critrevonc.2013.08.004. Epub 2013 Aug 28. Crit Rev Oncol Hematol. 2014. PMID: 24029605 Review.
The role of interleukin-6 in gynaecological malignancies.
Coward JI, Kulbe H. Coward JI, et al. Cytokine Growth Factor Rev. 2012 Dec;23(6):333-42. doi: 10.1016/j.cytogfr.2012.08.005. Epub 2012 Sep 30. Cytokine Growth Factor Rev. 2012. PMID: 23031497 Review.
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Clingan P, Ladwa R, Brungs D, Harris DL, McGrath M, Arnold S, Coward J, Fourie S, Kurochkin A, Malan DR, Mant A, Sharma V, Shue H, Tazbirkova A, Berciano-Guerrero MA, Charoentum C, Dalle S, Dechaphunkul A, Dudnichenko O, Koralewski P, Lugowska I, Montaudié H, Muñoz-Couselo E, Sriuranpong V, Oliviero J, Desai J. Clingan P, et al. Among authors: coward j. J Immunother Cancer. 2023 Oct;11(10):e007637. doi: 10.1136/jitc-2023-007637. J Immunother Cancer. 2023. PMID: 37848259 Free PMC article.
Chemotherapy advances in small-cell lung cancer.
Chan BA, Coward JI. Chan BA, et al. Among authors: coward ji. J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S565-78. doi: 10.3978/j.issn.2072-1439.2013.07.43. J Thorac Dis. 2013. PMID: 24163749 Free PMC article. Review.
Rethinking ovarian cancer: recommendations for improving outcomes.
Vaughan S, Coward JI, Bast RC Jr, Berchuck A, Berek JS, Brenton JD, Coukos G, Crum CC, Drapkin R, Etemadmoghadam D, Friedlander M, Gabra H, Kaye SB, Lord CJ, Lengyel E, Levine DA, McNeish IA, Menon U, Mills GB, Nephew KP, Oza AM, Sood AK, Stronach EA, Walczak H, Bowtell DD, Balkwill FR. Vaughan S, et al. Among authors: coward ji. Nat Rev Cancer. 2011 Sep 23;11(10):719-25. doi: 10.1038/nrc3144. Nat Rev Cancer. 2011. PMID: 21941283 Free PMC article.
New perspectives on targeted therapy in ovarian cancer.
Coward JI, Middleton K, Murphy F. Coward JI, et al. Int J Womens Health. 2015 Feb 4;7:189-203. doi: 10.2147/IJWH.S52379. eCollection 2015. Int J Womens Health. 2015. PMID: 25678824 Free PMC article. Review.
216 results